Serum hepatitis B surface antigen levels predict treatment response to nucleos(t)ide analogues

Quantification of hepatitis B surface antigen (HBsAg) has been suggested to be helpful in the management of chronic hepatitis B (CHB) patients. Nucleos(t)ide analogs (NAs) are the therapy of choice for CHB and are used in the majority of CHB patients. NAs are able to induce hepatitis B virus (HBV) v...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chen, Chien-Hung, Chiu, Yi-Chun, Lu, Sheng-Nan, Lee, Chuan-Mo, Wang, Jing-Houng, Hu, Tsung-Hui, Hung, Chao-Hung
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2014
Témata:
Topic Highlight
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069297/
https://ncbi.nlm.nih.gov/pubmed/24976706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i24.7686
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky